Fair Value Of Financial Instruments (Tables)

12 Months Ended

Jun. 30, 2018

Fair Value Of Financial Instruments [Abstract]


		Sensitivity for
		fair value of
		Cell C investment
EBITDA multiple of 6.25 times	$	153,724
EBITDA multiple of 6.75 times		172,948
EBITDA multiple of 7.25 times	$	192,172

Fair Value Of Assets And Liabilities Measured On Recurring Basis

The following table presents the Company's assets and liabilities measured at fair value on a recurring basis as of June 2018, according to the fair value hierarchy:


		Quoted price in		Significant
		active markets		other		Significant
		for identical		observable		unobservable
		assets		inputs		inputs
		(Level 1)		(Level 2)		(Level 3)		Total
Assets
Investment in Cell C	$	-	$	-	$	172,948	$	172,948
Related to insurance business:
Cash and cash equivalents (included in other
long-term assets)		610		-		-		610
Fixed maturity investments (included in
cash and cash equivalents)		8,304		-		-		8,304
Other		-		18		-		18
Total assets at fair value	$	8,914	$	18	$	172,948	$	181,880

Liabilities
DNI contingent consideration (Note 3)	$	-	$	-	$	27,222	$	27,222
Total liabilities at fair value	$	-	$	-	$	27,222	$	27,222

The following table presents the Company's assets measured at fair value on a recurring basis as of June 30, 2017, according to the fair value hierarchy:


		Quoted
		Price in
		Active		Significant
		Markets for		Other	Significant
		Identical		Observable	Unobservable
		Assets		Inputs	Inputs
		(Level 1)		(Level 2)	(Level 3)		Total
Assets
Related to insurance business:
Cash and cash equivalents (included in other
long-term assets)	$	627	$	-	$-	$	627
Fixed maturity investments (included in
cash and cash equivalents)		5,160		-	-		5,160
Other		-		37	-		37
Total assets at fair value	$	5,787	$	37	$-	$	5,824